• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在复发性艰难梭菌诱导的假膜性结肠炎中给予丙种球蛋白,其对毒素A的抗体反应存在缺陷。

Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A.

作者信息

Warny M, Denie C, Delmée M, Lefebvre C

机构信息

Département de Microbiologie, Université Catholique de Louvain, Bruxelles, Belgique.

出版信息

Acta Clin Belg. 1995;50(1):36-9. doi: 10.1080/17843286.1995.11718419.

DOI:10.1080/17843286.1995.11718419
PMID:7537003
Abstract

A 53-year-old woman suffered six episodes of Clostridium difficile-pseudomembranous colitis. The serological follow-up demonstrated the absence of a rise in IgG and IgA to toxin A. Human pooled gamma globulin was administered during the fifth relapse and raised IgG levels to toxin A. Normal stools reappeared a week later. The role of the antibodies to toxin A and gamma globulin in C. difficile colitis are discussed.

摘要

一名53岁女性患艰难梭菌假膜性结肠炎6次。血清学随访显示,针对毒素A的IgG和IgA未升高。在第五次复发期间给予人混合丙种球蛋白,使针对毒素A的IgG水平升高。一周后再次出现正常粪便。讨论了针对毒素A的抗体和丙种球蛋白在艰难梭菌结肠炎中的作用。

相似文献

1
Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A.在复发性艰难梭菌诱导的假膜性结肠炎中给予丙种球蛋白,其对毒素A的抗体反应存在缺陷。
Acta Clin Belg. 1995;50(1):36-9. doi: 10.1080/17843286.1995.11718419.
2
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.静脉注射丙种球蛋白治疗艰难梭菌毒素引起的慢性复发性结肠炎。
J Pediatr. 1991 Apr;118(4 Pt 1):633-7. doi: 10.1016/s0022-3476(05)83393-1.
3
Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii.一名选择性IgG1缺乏症患者接受静脉注射免疫球蛋白和布拉酵母菌治疗后出现复发性艰难梭菌感染
Clin Infect Dis. 1995 Jun;20 Suppl 2:S266-8. doi: 10.1093/clinids/20.supplement_2.s266.
4
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.针对毒素A的抗体反应与预防艰难梭菌复发性腹泻之间的关联。
Lancet. 2001 Jan 20;357(9251):189-93. doi: 10.1016/S0140-6736(00)03592-3.
5
Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors.与健康献血者相比,艰难梭菌感染患者抗毒素反应的诱导情况。
Anaerobe. 2016 Oct;41:91-103. doi: 10.1016/j.anaerobe.2016.07.001. Epub 2016 Jul 15.
6
Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea.酶联免疫吸附测定法(ELISA)检测伪膜性结肠炎和抗生素相关性腹泻患者体内艰难梭菌毒素抗体。
J Immunol Methods. 1983 Jun 10;60(3):341-50. doi: 10.1016/0022-1759(83)90291-0.
7
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.静脉注射免疫球蛋白治疗重症艰难梭菌结肠炎
Gut. 1997 Sep;41(3):366-70. doi: 10.1136/gut.41.3.366.
8
Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea.普通人群及抗生素相关性腹泻患者体内针对艰难梭菌毒素A和毒素B的免疫球蛋白G
Diagn Microbiol Infect Dis. 1994 Apr;18(4):205-9. doi: 10.1016/0732-8893(94)90021-3.
9
John G. Bartlett: Contributions to the discovery of Clostridium difficile antibiotic-associated diarrhea.约翰·G·巴特利特:艰难梭菌相关性抗生素腹泻发现的贡献。
Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S66-70. doi: 10.1093/cid/ciu419.
10
Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.艰难梭菌感染患者对毒素A的全身和黏膜抗体反应。
J Infect Dis. 1992 Dec;166(6):1287-94. doi: 10.1093/infdis/166.6.1287.

引用本文的文献

1
Recurrent Infection: Risk Factors, Treatment, and Prevention.反复感染:危险因素、治疗和预防。
Gut Liver. 2019 Jan 15;13(1):16-24. doi: 10.5009/gnl18071.
2
Leaping Forward in the Treatment of Infection: Update in 2015.感染治疗的飞跃:2015年最新进展
GE Port J Gastroenterol. 2015 Aug 31;22(6):259-267. doi: 10.1016/j.jpge.2015.07.006. eCollection 2015 Nov-Dec.
3
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.从粪便微生物群移植和益生菌研究中获取见解,以合理设计联合微生物疗法。
Clin Microbiol Rev. 2017 Jan;30(1):191-231. doi: 10.1128/CMR.00049-16.
4
Recurrent C. difficile in a Patient with IgG Deficiency.一名患有IgG缺乏症患者的艰难梭菌反复感染
Case Rep Gastrointest Med. 2015;2015:356293. doi: 10.1155/2015/356293. Epub 2015 Apr 5.
5
Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review.静脉注射用免疫球蛋白治疗艰难梭菌感染:综述。
Dig Dis Sci. 2011 Jan;56(1):19-26. doi: 10.1007/s10620-010-1411-2. Epub 2010 Oct 6.
6
Review of medical and surgical management of Clostridium difficile infection.艰难梭菌感染的医学和手术治疗综述。
Tech Coloproctol. 2010 Jun;14(2):97-105. doi: 10.1007/s10151-010-0574-3. Epub 2010 May 8.
7
Clostridium difficile infection in the intensive care unit.重症监护病房中的艰难梭菌感染
Infect Dis Clin North Am. 2009 Sep;23(3):727-43. doi: 10.1016/j.idc.2009.04.011.
8
Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea.静脉注射免疫球蛋白治疗复发性艰难梭菌腹泻
Gut. 2002 Sep;51(3):456. doi: 10.1136/gut.51.3.456.
9
Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.布拉酵母菌刺激小鼠肠道对艰难梭菌毒素A的免疫球蛋白A免疫反应。
Infect Immun. 2001 Apr;69(4):2762-5. doi: 10.1128/IAI.69.4.2762-2765.2001.
10
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.给予健康成年人递增剂量艰难梭菌类毒素疫苗的安全性和免疫原性。
Infect Immun. 2001 Feb;69(2):988-95. doi: 10.1128/IAI.69.2.988-995.2001.